- Home
- ACHC vs CORT Comparison
ACHC vs CORT Comparison
Compare ACHC & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHC
- CORT
- Stock Information
- Founded
- ACHC 2005
- CORT 1998
- Country
- ACHC United States
- CORT United States
- Employees
- ACHC N/A
- CORT N/A
- Industry
- ACHC Medical Specialities
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- ACHC Health Care
- CORT Health Care
- Exchange
- ACHC Nasdaq
- CORT Nasdaq
- Market Cap
- ACHC 2.1B
- CORT 7.1B
- IPO Year
- ACHC N/A
- CORT N/A
- Fundamental
- Price
- ACHC $26.15
- CORT $75.08
- Analyst Decision
- ACHC Strong Buy
- CORT Strong Buy
- Analyst Count
- ACHC 10
- CORT 4
- Target Price
- ACHC $52.25
- CORT $142.00
- AVG Volume (30 Days)
- ACHC 3.2M
- CORT 1.3M
- Earning Date
- ACHC 05-12-2025
- CORT 05-05-2025
- Dividend Yield
- ACHC N/A
- CORT N/A
- EPS Growth
- ACHC N/A
- CORT 8.36
- EPS
- ACHC 2.04
- CORT 1.14
- Revenue
- ACHC $3,156,417,000.00
- CORT $685,446,000.00
- Revenue This Year
- ACHC $7.90
- CORT $35.85
- Revenue Next Year
- ACHC $8.58
- CORT $35.22
- P/E Ratio
- ACHC $12.79
- CORT $65.80
- Revenue Growth
- ACHC 5.48
- CORT 30.93
- 52 Week Low
- ACHC $20.36
- CORT $25.35
- 52 Week High
- ACHC $82.41
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- ACHC 54.98
- CORT 57.68
- Support Level
- ACHC $24.41
- CORT $68.86
- Resistance Level
- ACHC $28.48
- CORT $73.36
- Average True Range (ATR)
- ACHC 1.34
- CORT 3.26
- MACD
- ACHC 0.63
- CORT 0.12
- Stochastic Oscillator
- ACHC 67.55
- CORT 95.28
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.